NPPA revised Retail Price of 93 scheduled formulations: January 2023

Download NPPA notification No. S.O. S.O. 87(E) dt 06-01-2023, the link is given below: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 4 scheduled formulations vide vide S.O. 87(E) dt 06-01-2023 based on the decision of 106th Authority meeting dated 30.12.2022

This price fixation followed the decision of the 106th Authority meeting on December 30, 2022.

In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No SO
1499(E) dated 30th March, 2022 in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table herein below as ceiling price exclusive of goods
and services tax applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

Table

TABLE

Sl. No. Name of the Scheduled Formulation   Dosage form and strength   Unit Ceiling Price (Rs.)
(1) (2) (3) (4) (5)
1 Sulfasalazine Tablet 500 mg 1 Tablet 4.21
2 Digoxin Tablet 0.25mg 1 Tablet 1.19
3 Ethambutol Tablet 600mg 1 Tablet 3.64
4 Phenytoin Tablet 300mg 1 Tablet 4.89
  5 Atazanavir (A) +Ritonavir(B) Tablet 300mg(A) + Tablet 100mg(B)   1 Tablet   89.03
6 Ceftriaxone Powder for Injection 500 mg 1 Vial 44.84
7 Ceftriaxone Powder for Injection 250 mg 1 Vial 25.28
8 Ceftriaxone Powder for Injection 1000mg 1 Vial 55.64
9 Ceftriaxone Powder for Injection 2000mg 1 Vial 123.18
10 Cefotaxime Powder for Injection 250 mg 1 Vial 15.80
11 Cefotaxime Powder for Injection 500 mg 1 Vial 21.74
12 Cefotaxime Powder for Injection 1000mg 1 Vial 35.64
  13 Piperacillin (A) +Tazobactam(B) Powder for Injection 1000mg(A)+125mg(B)   1 Vial   88.88
  14 Piperacillin (A) +Tazobactam(B) Powder for Injection 2000mg(A)+250mg(B)   1 Vial   170.83
  15 Piperacillin (A) +Tazobactam(B) Powder for Injection 4000mg(A)+500mg(B)   1 Vial   356.21
16 Ampicillin Powder for Injection 500 mg 1 Vial 12.71
17 Metoprolol Tablet 25mg 1 Tablet 3.75
18 Metoprolol Tablet 50mg 1 Tablet 5.21
19 Propranolol Tablet 40mg 1 Tablet 2.87
20 Fluconazole Tablet 200mg 1 Tablet 15.57
21 Ethambutol Tablet 800mg 1 Tablet 4.42
22 Pyrazinamide Tablet 1000mg 1 Tablet 9.39
23 Pyrazinamide Tablet 500mg 1 Tablet 4.36
24 Pyrazinamide Tablet 750mg 1 Tablet 6.43
25 Phenobarbitone Tablet 30mg 1 Tablet 1.17
26 Amiodarone Tablet 200mg 1 Tablet 10.27
27 Ethambutol Tablet 400mg 1 Tablet 2.33
28 Fluconazole Tablet 100mg 1 Tablet 6.80
29 Azathioprine Tablet 50mg 1 Tablet 10.04
30 Allopurinol Tablet 100mg 1 Tablet 1.69
31 Propranolol Tablet 10mg 1 Tablet 1.17
32 Hydroxychloroquine Tablet 200mg 1 Tablet 5.67
33 Carbimazole Tablet 10mg 1 Tablet 3.80
34 Cefixime Tablet 200mg 1 Tablet 8.72
35 Imatinib Tablet 100mg 1 Tablet 62.21
36 Tamoxifen Tablet 20mg 1 Tablet 2.63
37 Tamoxifen Tablet 10mg 1 Tablet 1.97
38 L-Asparaginase Powder for Injection 5000 KU 1 Vial 922.94
  39   L-Asparaginase Powder for Injection 10000KU   1 Vial   1523.03
40 Dacarbazine Powder for Injection 200mg 1 Vial 340.46
41 Mefloquine Tablet 250 mg 1 Tablet 46.52
42 Thalidomide Capsule 50 mg 1 Capsule 27.79
43 Thalidomide Capsule 100mg 1 Capsule 55.31
44 Clonazepam Tablet 0.25mg 1 Tablet 1.80
45 Clonazepam Tablet 0.5mg 1 Tablet 3.08
46 Clonazepam Tablet 1mg 1 Tablet 4.25
47 Clozapine Tablet 25mg 1 Tablet 2.48
48 Clozapine Tablet 50mg 1 Tablet 4.63
49 Clozapine Tablet 100 mg 1 Tablet 7.54
50 Metronidazole Tablet 200mg 1 Tablet 0.73
51 Metronidazole Tablet 400mg 1 Tablet 1.36
52 Hydroxyurea Capsule 500mg 1 Capsule 10.81
53 Ibuprofen Tablet 200mg 1 Tablet 0.63
54 Acetazolamide Tablet 250mg 1 Tablet 3.62
55 Ciprofloxacin Tablet 250mg 1 tablet 1.96
56 Salbutamol Tablet 4 mg 1 Tablet 0.19
57 Salbutamol Tablet 2 mg 1 Tablet 0.16
58 Metoclopramide Tablet 10mg 1 Tablet 1.20
  59 Amoxicillin (A) +Clavulanic acid (B) Tablet 500 mg (A) + 125 mg (B)   1 Tablet   16.32
60 Docetaxel Powder for Injection 20mg 1 Vial 2558.14
61 Clopidogrel Tablet 75mg 1 Tablet 5.94
62 Hydrocortisone Powder for Injection 100mg 1 Vial 39.95
63 Gemcitabine Powder for Injection 1000mg 1 Vial 4987.65
64 Methotrexate Tablet 10mg 1 tablet 11.85
65 Methotrexate Tablet 2.5mg 1 tablet 4.74
66 Diltiazem Tablet 60mg 1 Tablet 4.87
67 Amiodarone Tablet 100mg 1 Tablet 5.48
68 Dom1idone Tablet 10mg 1 Tablet 2.06
69 Quinine Tablet 300 mg 1 Tablet 5.04
70 Enalapril Tablet 5mg 1 Tablet 3.30
71 Enalapril Tablet 2.5mg 1 Tablet 1.95
72 Acyclovir Tablet 400mg 1 Tablet 12.18
73 Acyclovir Tablet 200mg 1 Tablet 6.79
74 Rifampicin Capsule 450mg 1 Capsule 5.06
  75 Zidovudine (A) +Lamivudine(B)   Tablet 300mg(A)+150mg(B)   1 Tablet   18.81
76 Primaquine Tablet 7.5mg 1 Tablet 2.12
77 Nitrofurantoin Tablet 100 mg 1 Tablet 7.23
78 Ciprofloxacin Tablet 500mg 1 tablet 3.79
79 Ondansetron Tablet 8 mg 1 Tablet 7.94
80 Griseofulvin Tablet 250mg 1 Tablet 1.58
81 Escitalopram Tablet 5mg 1 Tablet 4.48
82 Escitalopram Tablet 10mg 1 Tablet 8.03
83 Escitalopram Tablet 20mg 1 Tablet 12.81
84 Gemcitabine Powder for Injection 200 mg 1 Vial 1159.21
85 Ceftazidime Powder for Injection 1000mg 1 Vial 202.47
86 Diclofenac Tablet 50mg 1 Tablet 1.83
87 Carbamazepine Tablet 200mg 1 Tablet 1.40
  88 Amoxicillin (A) + Clavulanic acid (B) Powder for Injection 1 g (A) +200mg (B)   1 Vial   125.44
89 Bisacodyl Tablet 5mg 1 Tablet 1.04
90 Pantoprazole Injection 40mg 1 Vial 45.00
  91 Ethinylestradiol (A)+ Levonorgestrel (B) Tablet 0.03mg(A) + Tablet 0.15mg(B)   1 Tablet   2.83
92 Norethisterone Tablet 5mg 1 Tablet 4.81
93 Carbimazole Tablet 5mg 1 Tablet 1.95

Note:
(a) All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.

(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above-said table.

(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO 2013.

The manufacturer shall issue a price list in Form–V from the date of the Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner to be easily accessible to any person wishing to consult the same.

(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule II of the DPCO, 2013.

(g) The manufacturers of above said scheduled formulations shall furnish quarterly returns to the NPPA, in respect of the production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS.

Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the DPCO 2013 read with Essential Commodities Act, 1955.

(i) Consequent to the issue of the ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above-said date of notification, stand(s) superseded.

  • Related Posts

    • Pharma
    • April 19, 2024
    • 53 views
    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

    • Pharma
    • April 19, 2024
    • 44 views
    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs